The round
- Raised
- $5.4M
- Filed
- Nov 4, 2026
- Based in
- Boston, MA
- Investors
- 7 in this round
- Legal name
- MitoAI Inc.
- Website
- mitochon.ai
About Mito AI
The problem
New cancer trials, studies and expert debate pile up faster than any team can read, so strategy reviews take weeks.
The usual way
Analysts spend weeks building each strategy review by hand.
What they built
Mito AI reads trials, papers, guidelines and conference data and turns them into answers with every claim traced to its source.
How it works
- GatherTrials, papers, conference data
- AnalyzeRivals, targets and next steps
- ReviewExperts check every source
Traction
Built for
Their website

The script
Every scene of the video: the narration, what's on screen, and a still from the final cut.
-

“Mito AI just raised five point four million dollars.”
On screen$5.4M · AI for cancer drug decisions
-

“Cancer drug teams face a flood of new trial results, studies and expert debate every week.”
On screenCancer research moves too fast.
New trials, studies and expert opinions pile up faster than any team can read.
-

“So analysts spend weeks reading and summarizing it by hand.”
On screenWeeks of manual reading.
Analysts spend weeks building each strategy review by hand.
-

“Mito AI reads it all and turns it into clear answers, with every claim linked to its source.”
On screenMeet Mito AI, answers with sources.
- Reads Trials, studies, guidelines
- Answers Which cancers to target next
- Proof Every output traced to source
-

“It gathers the evidence, runs the analysis, and experts review answers they can trace.”
On screenHow it works.
- Gather Trials, papers, conference data
- Analyze Rivals, targets and next steps
- Review Experts check every source
-

“Mito AI says it can turn a big conference readout into a briefing in under an hour.”
On screenWeeks of work, in an hour.
< 1 hr from new data to a briefing
-

“That's five point four million dollars, from seven investors.”
On screenBetter decisions for cancer care.
Boston, MA · 7 investors · Founded 2023
-

“Follow us for a new funded startup every day.”
On screenTomorrow: another startup that just got funded.
Caption, as posted
AI biotech startup Mito AI just raised $5.4M to help cancer drug teams turn a flood of research into clear, sourced answers. Follow @just.got.funded for a new funded startup every day. New cancer trials, studies and expert debate pile up faster than any team can read, so strategy reviews take weeks. Mito AI reads trials, papers, guidelines and conference data and turns them into answers with every claim traced to its source. Should AI help decide which cancer drugs get built next? 👇 Send this to someone who works in cancer research. #oncology #biotech #artificialintelligence #bostonstartups #justgotfunded
Sources
- SEC Form D filing: MitoAI Inc., filed Nov 4, 2026
- www.mitochon.ai